Immune system
A two-amino-acid peptide from Russian longevity research, studied for restoring immune balance and calming chronic inflammation. Human evidence is still thin.
Start here
Vilon is a two-amino-acid peptide bioregulator (Lys-Glu) studied for immune support and healthy aging. Reported research findings include stronger immune cell development, lower levels of inflammatory signaling molecules, and improved 2-year survival in elderly Stage III colorectal cancer patients when added to standard radiation and chemotherapy. It is a research compound, not FDA approved, with limited human trial evidence, given by injection; oral dosing has only been demonstrated in animal studies.
Vilon is a skin and connective tissue support peptide that promotes collagen production, improves skin elasticity, and enhances wound healing through activation of fibroblast (a cell that builds connective tissue) growth pathways.
Vilon is a bioactive peptide from collagen- and elastin-rich tissues. In dermal fibroblasts (the skin cells that make its supporting fibers), it switches on FGF (fibroblast growth factor) and TGF-β (transforming growth factor-beta) signaling, two growth-signal pathways. This raises production of type I and III collagen (the main proteins that keep skin firm) by turning up the COL1A1 and COL3A1 genes. It increases hyaluronic acid (a molecule that holds water in skin) by boosting the activity of hyaluronic acid synthase (HAS, the enzyme that makes it). It also promotes skin cell growth and maturation, strengthens the basement membrane (the thin layer anchoring skin layers together), and speeds wound healing by helping new blood vessels form and by turning on tissue-remodeling factors.
Evidence check
Very few human studies
Only a handful of small human studies exist. Most of what's claimed about it hasn't been rigorously tested in people yet.
Every numbered marker on this page links to one of the 6 sources at the bottom.
Immune System Revival
Vilon wakes up your thymus gland, the organ that trains immune cells, helping your body make more infection-fighting T cells as you age.
Healthy Aging
This peptide turns on SIRT1, a longevity gene that helps cells stay young and healthy, while calming down inflammation throughout your body.
Digestive Support
Vilon boosts digestive enzymes in your gut, helping your body break down and absorb nutrients better, especially as you get older.
The most-asked question
The research-reported range is 500 mcg, once daily. Studies used different doses for different situations — find yours:
Immune support research, First-time users
200–500 mcg
Common Khavinson-style introductory protocol for the KE (Lys-Glu) immune bioregulator; courses repeated 2–3 times yearly 6. Research use only — no approved product.
Immune modulation research, Cyclical protocols
500 mcg
Typical full-course practice dose; cycle repeated every 3–6 months 6.
Intensive immune research protocols
500 mcg
Intramuscular (into a muscle) delivery is also documented for the injectable KE bioregulator; same per-course dosing as subcutaneous (under the skin) 6.
The ceiling: 10 (as determined by your healthcare provider based on individual response and tolerance)
Reconstitution, in plain words
Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Vilon:
Add the recommended volume of bacteriostatic water to the Vilon vial. Gently swirl (do not shake) until the powder is fully dissolved. The resulting solution should be clear. Calculate your individual dose based on the concentration and your prescribed amount.
Your dose of Vilon is determined by your healthcare provider. Using an insulin syringe marked in units, draw up the exact amount prescribed. For example, if the reconstituted concentration is 1mg/mL and your dose is 0.5mg, draw up 0.5mL (50 units on an insulin syringe). Always double-check calculations before injection.
Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Vilon's recorded schedule.
Injection sites & technique
Injection into the fatty layer just under the skin—it is absorbed steadily, and you can give it yourself at home after proper training
Timing
Administer Vilon at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
Vilon injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
Vilon should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
The honest list
These show up most often. They usually fade as your body adjusts.
Mild redness, slight soreness, or minor swelling at the subcutaneous (under the skin) injection site. Common with injectable peptide bioregulators.
What to do Rotate injection sites between abdomen, thighs, and upper arms. Apply cold compress if needed. Resolves spontaneously within 24-48 hours.
Slight tiredness in the first days as your immune system resets in response to more active T-cells (a key type of immune cell) and shifting levels of immune signals.
What to do Rest as needed. Usually resolves within 2-3 days. Ensure adequate sleep and hydration.
A short-lived headache in the first few days of treatment, possibly linked to immune activation and changing levels of immune signals.
What to do Ensure adequate hydration. Standard analgesics if needed. Usually self-limiting.
Mild gastrointestinal changes (increased digestive activity, slight changes in bowel habits) reflecting Vilon's enhancement of digestive enzyme activity throughout the GI tract.
What to do Generally benign — indicates active enzyme normalization. Eat regular meals. Should stabilize within days.
Worth knowing about, but most people never see these.
A brief, mild flu-like reaction (low-grade fever, body aches) as the peptide activates T-cells (a key type of immune cell) and your immune signals adjust.
What to do Rest, hydrate, and monitor. Symptoms should resolve within 24-48 hours. If persistent, reduce dose for subsequent injections.
Rare, but if any of these happen, stop and contact a medical professional.
No serious adverse events, drug dependence, organ toxicity, or allergic reactions have been reported across all published clinical studies. No lethal dose has been established in animal toxicology research — dose-escalation studies could not reach lethal endpoints.
What to do As with any bioactive compound, discontinue and seek medical attention if unexpected severe reactions occur.
Week by week
Is it right for you?
Vilon should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
Use with caution—discuss with your healthcare provider.
May be used together under medical guidance.
May be used together under medical guidance.
May be used together under medical guidance.
Generally safe to take alongside Vilon. Space doses apart if taking oral formulations to ensure optimal absorption.
Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Vilon is particularly well-suited for individuals focused on immune system restoration in aging individuals with declining thymic function. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Vilon is particularly well-suited for individuals focused on adjunctive immunomodulatory support during cancer treatment protocols. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Vilon is particularly well-suited for individuals focused on geroprotective therapy targeting sirt1/parp pathways for cellular longevity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Vilon is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols for anti-aging and immune support. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Vilon (immunomodulatory thymic peptide complex from bovine thymus) demonstrates favorable safety in Russian/Eastern European medical use over 20+ years with minimal documented serious adverse events in published literature. Bovine-derived peptide preparations carry theoretical prion disease risk (variant Creutzfeldt-Jakob disease) though processing methods and regulatory standards substantially reduce this risk. Common adverse effects are mild—local injection site reactions, transient fever, or lymphadenopathy—consistent with immune system stimulation rather than toxicity.
Safety data comes primarily from Russian clinical experience and unpublished manufacturer studies; limited peer-reviewed Western data exists. No Phase 3 controlled efficacy trials have been published in major journals. Immunostimulatory mechanism could theoretically exacerbate autoimmune conditions, requiring baseline immune status assessment. Long-term safety beyond 2-3 months of use is incompletely characterized in English-language literature.
Keeping it good
Store Vilon in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
Once reconstituted, Vilon should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Not our opinion — the published record
2023
Vilon peptide (KE) regulates longevity genes by activating SIRT1 (a gene that helps cells stay healthy as they age) and suppressing PARP1/PARP2 (DNA-repair proteins linked to aging), with anti-aging effects that work through binding to DNA.
Khavinson VK, Linkova NS, Ashapkin VV
2023
Research (2023) on vilon contributes important scientific knowledge about its biological and pharmacological properties.
Linkova N, Khavinson V, Diatlova A
2022
Chonluten peptide and other tissue-specific peptides suppress TNF and inflammatory cytokines (inflammation signals) in immune cells, acting as natural inducers of inflammation tolerance (training the body to hold back inflammation) during infections and tissue damage.
Avolio F, Martinotti S, Khavinson VK
2013
Research (2013) on vilon contributes important scientific knowledge about its biological and pharmacological properties.
Sevostianova NN, Linkova NS, Polyakova VO
2002
Research (2002) on vilon contributes important scientific knowledge about its biological and pharmacological properties.
Khavinson VKh, Rybakina EG, Malinin VV
2024
Project Biohacking (Khavinson bioregulator reference)
If this isn't the right fit
Your questions
Vilon is a synthetic dipeptide (Lys-Glu, or KE, two linked amino acids). It was identified as a key immune-modulating part of Thymalin, a drug made from natural extracts of the thymus (an immune organ). Thymalin is a complex mixture of thymus peptides. Vilon is the purified, lab-made version of just the KE piece, offering the targeted immune-balancing and anti-aging effects of that one component. Studies have confirmed that the KE dipeptide drives much of Thymalin's T-cell activation (T-cells are a key type of immune cell), regulation of immune signals, and anti-inflammatory activity.
In direct comparisons, Vilon (KE) had the strongest effect on thymocyte growth (young immune cells multiplying) among the tested Khavinson bioregulators. It beat both Epithalon (AEDG, a pineal gland bioregulator) and Cortagen (AEDP, a brain bioregulator). Vilon also switched on the sphingomyelin pathway (a cell-signaling route in immune cells) more strongly. Epithalon specializes in pineal gland and melatonin function and Cortagen in nerve protection, while Vilon is the most potent immune-specific bioregulator in the Khavinson family.
SIRT1 (sirtuin-1) is an enzyme that needs NAD+ (a cell energy helper molecule) to work. It is considered a master longevity regulator: it promotes DNA repair, telomere (the protective cap on a chromosome) maintenance (protecting chromosome ends), resistance to oxidative stress (cell damage from unstable oxygen molecules), and efficient metabolism. PARP1 and PARP2 (enzymes that compete with SIRT1 for NAD+) become overactive with age, using up the NAD+ available to SIRT1. Vilon rebalances this by turning SIRT1 up (6-8.2 fold) and turning PARP1/PARP2 down (2.1-5.3 fold), steering NAD+ back toward longevity pathways. This two-part action is considered one of the most direct ways to target the basic mechanisms of aging.
Published clinical evidence supports Vilon as an adjunctive therapy for cancer patients. In a study of elderly Stage III colorectal cancer patients, adding Vilon to standard radio/chemotherapy improved 2-year survival, reduced post-operative complications, prevented tumor recurrence and dissemination, and improved quality of life. In animal models, Vilon reduced urinary bladder tumor incidence from 75.5% to 56% with a 2-fold decrease in pre-neoplastic lesions. These oncostatic effects are attributed to activation of heterochromatin-silenced genes and inhibition of reactive oxygen species formation.
Vilon (Lys-Glu) is one of the smallest bioactive peptides known, and its efficacy has been extensively documented across dozens of peer-reviewed studies. The KE dipeptide achieves biological activity through direct interaction with specific DNA sequences (GCGG in B-form DNA, GGGC in nucleosomal DNA) in gene promoter regions. This ultra-short structure actually provides advantages: efficient cellular uptake via peptide transporters, direct nuclear penetration without carrier proteins, and rapid tissue distribution. The specificity comes not from the peptide's size but from its precise fit into DNA promoter sequences of target genes.
Conventional immune stimulants broadly rev up the immune system. Vilon works by adjusting gene activity to restore proper immune function. It boosts adaptive immunity (the targeted, learned part of the immune system) by helping T-cells mature through the CD5/CD4/CD8 pathway (markers on T-cells), while lowering harmful inflammation (reducing IL-1β, IL-6, and TNF-α, inflammatory immune signals). This two-way action, boosting helpful immune responses while damping harmful inflammation, is very different from simple immune stimulation. It explains why Vilon could help in both immune deficiency and inflammatory conditions.
6 sources
Every numbered marker on this page points to one of these. Same sources, same numbering as the Vilon research profile on Peptide Initiative.
Want the deep science?
Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.
Open the research profileThis guide is education, not medical advice. Vilon is a research compound that is not FDA-approved for human use. Talk to a clinician before taking anything.
PeptideGeek